Noncalcified plaque burden quantified from coronary computed tomography angiography improves prediction of side branch occlusion after main vessel stenting in bifurcation lesions: results from the CT-PRECISION registry.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 21 03 2020
accepted: 26 04 2020
pubmed: 10 5 2020
medline: 18 8 2021
entrez: 10 5 2020
Statut: ppublish

Résumé

To assess the incremental value of quantitative plaque features measured from computed tomography angiography (CTA) for predicting side branch (SB) occlusion in coronary bifurcation intervention. We included 340 patients with 377 bifurcation lesions in the post hoc analysis of the CT-PRECISION registry. Each bifurcation was divided into three segments: the proximal main vessel (MV), the distal MV, and the SB. Segments with evidence of coronary plaque were analyzed using semi-automated software allowing for quantitative analysis of coronary plaque morphology and stenosis. Coronary plaque measurements included calcified and noncalcified plaque volumes, and corresponding burdens (respective plaque volumes × 100%/vessel volume), remodeling index, and stenosis. SB occlusion occurred in 28 of 377 bifurcation lesions (7.5%). The presence of visually identified plaque in the SB segment, but not in the proximal and distal MV segments, was the only qualitative parameter that predicted SB occlusion with an area under the curve (AUC) of 0.792. Among quantitative plaque parameters calculated for the SB segment, the addition of noncalcified plaque burden (AUC 0.840, p = 0.003) and low-density plaque burden (AUC 0.836, p = 0.012) yielded significant improvements in predicting SB occlusion. Using receiver operating characteristic curve analysis, optimal cut-offs for noncalcified plaque burden and low-density plaque burden were > 33.6% (86% sensitivity and 78% specificity) and > 0.9% (89% sensitivity and 73% specificity), respectively. CTA-derived noncalcified plaque burden, when added to the visually identified SB plaque, significantly improves the prediction of SB occlusion in coronary bifurcation intervention. ClinicalTrials.gov Identifier: NCT03709836 registered on October 17, 2018.

Identifiants

pubmed: 32385529
doi: 10.1007/s00392-020-01658-1
pii: 10.1007/s00392-020-01658-1
pmc: PMC7806530
doi:

Banques de données

ClinicalTrials.gov
['NCT03709836']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-123

Subventions

Organisme : National Institute of Cardiology, Warsaw, Poland
ID : 2.43/III/16

Références

J Am Coll Cardiol. 2004 Mar 3;43(5):842-7
pubmed: 14998627
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):259-268
pubmed: 27029714
Am J Cardiol. 2020 May 15;125(10):1479-1485
pubmed: 32276762
Radiology. 2010 Nov;257(2):516-22
pubmed: 20829536
Am J Cardiol. 2019 Oct 1;124(7):1012-1019
pubmed: 31351575
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):39-46
pubmed: 25616815
JAMA Cardiol. 2018 Sep 1;3(9):858-863
pubmed: 30027285
EuroIntervention. 2019 Oct 04;15(9):e788-e795
pubmed: 30636682
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
JACC Cardiovasc Interv. 2016 Apr 25;9(8):862-865
pubmed: 27101914
J Am Heart Assoc. 2018 May 25;7(11):
pubmed: 29802145
EuroIntervention. 2015;11 Suppl V:V75-7
pubmed: 25983177
EuroIntervention. 2016 May 17;12(1):38-46
pubmed: 27173860
JACC Cardiovasc Imaging. 2008 Jul;1(4):460-71
pubmed: 19356468
Clin Res Cardiol. 2018 Aug;107(Suppl 2):64-73
pubmed: 29978353
EuroIntervention. 2012 Feb;7(10):1147-54
pubmed: 22030298
Radiology. 2014 Jun;271(3):711-20
pubmed: 24576047
Clin Res Cardiol. 2018 Aug;107(Suppl 2):40-48
pubmed: 29974195
Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):499-507
pubmed: 28025263
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1075-82
pubmed: 23592548
J Thorac Imaging. 2018 Jan;33(1):35-54
pubmed: 28394783
J Am Coll Cardiol. 2013 Oct 29;62(18):1654-1659
pubmed: 23954335
Invest Radiol. 2011 Dec;46(12):790-5
pubmed: 21826008
Curr Cardiovasc Imaging Rep. 2017;10(5):15
pubmed: 28446943
Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):810-817
pubmed: 30690861
JACC Cardiovasc Interv. 2011 Feb;4(2):198-208
pubmed: 21349459
Circ Cardiovasc Interv. 2010 Apr;3(2):113-9
pubmed: 20407111
J Cardiovasc Comput Tomogr. 2020 May - Jun;14(3):258-265
pubmed: 31806391
Eur J Radiol. 2015 Aug;84(8):1502-1508
pubmed: 26001435
J Cardiovasc Comput Tomogr. 2016 Sep-Oct;10(5):384-5
pubmed: 27495380
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Clin Res Cardiol. 2020 Sep;109(9):1186-1192
pubmed: 32034482
Radiol Cardiothorac Imaging. 2019 Dec 19;1(5):e190069
pubmed: 32076671
Circ Cardiovasc Interv. 2012 Oct;5(5):657-62
pubmed: 23031838

Auteurs

Kajetan Grodecki (K)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.
Medical University of Warsaw, Warsaw, Poland.
Biomedical Imaging Research Institute and Artificial Intelligence in Medicine Program, Departments of Biomedical Sciences and Medicine Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Sebastien Cadet (S)

Biomedical Imaging Research Institute and Artificial Intelligence in Medicine Program, Departments of Biomedical Sciences and Medicine Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Adam D Staruch (AD)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.

Anna M Michalowska (AM)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.
Medical University of Warsaw, Warsaw, Poland.

Cezary Kepka (C)

Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Rafal Wolny (R)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.

Jerzy Pregowski (J)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.

Mariusz Kruk (M)

Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Mariusz Debski (M)

Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland.

Artur Debski (A)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.

Ilona Michalowska (I)

Department of Radiology, National Institute of Cardiology, Warsaw, Poland.

Piotr J Slomka (PJ)

Biomedical Imaging Research Institute and Artificial Intelligence in Medicine Program, Departments of Biomedical Sciences and Medicine Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Adam Witkowski (A)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland.

Damini Dey (D)

Biomedical Imaging Research Institute and Artificial Intelligence in Medicine Program, Departments of Biomedical Sciences and Medicine Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Maksymilian P Opolski (MP)

Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Alpejska 42, 04-628, Warsaw, Poland. mopolski@ikard.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH